Induced Pluripotent Stem Cells Market Overview, Opportunities and Development 2031

Induced Pluripotent Stem Cells Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Derived Cell Type (Hepatocytes, Fibroblasts); Application (Drug Development); End-use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00040167
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

The Induced Pluripotent Stem Cells Market is expected to register a CAGR of 10.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Derived Cell Type (Hepatocytes, Fibroblasts), Application (Drug Development), End-use (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Others). The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Induced Pluripotent Stem Cells Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Induced Pluripotent Stem Cells Market Segmentation

Derived Cell Type
  • Hepatocytes
  • Fibroblasts
Application
  • Drug Development
End-use
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies

Strategic Insights

Induced Pluripotent Stem Cells Market Growth Drivers
  • Advancements in Stem Cell Technology: Ongoing advancements in stem cell research, particularly in the development of induced pluripotent stem cells (iPSCs), have revolutionized regenerative medicine. iPSCs allow for the creation of patient-specific cell lines, overcoming ethical concerns related to embryonic stem cells, and significantly driving market demand for applications in drug development, tissue regeneration, and disease modeling.
  • Increasing Investment in Stem Cell Research: There is a significant rise in public and private sector investment in stem cell research, particularly in iPSC technology. Governments, research institutes, and pharmaceutical companies are allocating substantial funding to explore the therapeutic potential of iPSCs for various conditions, such as neurodegenerative diseases and genetic disorders, thus boosting market growth.
  • Rising Demand for Personalized Medicine: With the increasing focus on personalized medicine, iPSCs offer a promising solution for developing tailored treatments. They enable researchers to create patient-specific models, which can be used for drug testing, reducing adverse drug reactions, and optimizing therapies. This demand for personalized treatments has accelerated the adoption of iPSC technology across the healthcare sector.
Induced Pluripotent Stem Cells Market Future Trends
  • Integration of CRISPR Technology: The integration of CRISPR-Cas9 gene-editing technology with iPSC research is a growing trend. By enabling precise genetic modifications in iPSCs, CRISPR technology enhances the ability to develop disease models, correct genetic defects, and accelerate the development of personalized therapies. This combination is advancing the potential of iPSCs in clinical and pharmaceutical applications.
  • Shift Toward Drug Discovery and Toxicology Testing: There is a growing trend to use iPSCs in drug discovery and toxicology testing. iPSCs allow for the creation of human disease models, providing a more accurate representation of human physiology compared to animal models. This trend is transforming the drug development process by improving the efficacy and safety of new compounds before clinical trials.
  • Collaborations with Pharmaceutical and Biotech Companies: Increasing partnerships between iPSC technology companies and pharmaceutical or biotech firms are accelerating research and development. These collaborations focus on leveraging iPSCs for new drug discoveries, disease modeling, and regenerative therapies. The combination of iPSC technology with industry expertise is expanding its therapeutic and commercial applications in regenerative medicine and drug testing.
Induced Pluripotent Stem Cells Market Opportunities
  • Therapeutic Applications for Regenerative Medicine: iPSCs hold immense promise for regenerative medicine, offering potential treatments for conditions such as heart disease, spinal cord injuries, and neurodegenerative disorders. As research progresses, the development of iPSC-based therapies presents opportunities to revolutionize the treatment of previously untreatable conditions, expanding market opportunities for biotechnology and healthcare companies.
  • Expansion of iPSC-Based Drug Development Platforms: The development of iPSC-based drug screening platforms presents significant growth opportunities in the pharmaceutical industry. These platforms can help identify drug candidates more efficiently, reduce testing costs, and improve drug safety profiles. As the demand for faster and more accurate drug discovery rises, companies are increasingly adopting iPSC-based models for testing novel compounds.
  • Growth in Cell-Based Therapies: The rising interest in cell-based therapies presents a major opportunity for the iPSC market. iPSCs can generate a wide variety of cell types, making them suitable for treating conditions like diabetes, Parkinson's disease, and retinal degeneration. As the acceptance of cell-based therapies grows, the market for iPSC-derived treatments is expected to expand rapidly.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Induced Pluripotent Stem Cells Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Induced Pluripotent Stem Cells Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the induced pluripotent stem cells market?

The induced pluripotent stem cells market is estimated to witness a CAGR of 10.2% from 2025 to 2031

What are the driving factors impacting the induced pluripotent stem cells market?

The major factors driving the induced pluripotent stem cells market are:

1.Advancements in Stem Cell Technology

2. Increasing Investment in Stem Cell Research

3. Rising Demand for Personalized Medicine

Which region dominated the induced pluripotent stem cells market in 2024?

North America region dominated the induced pluripotent stem cells market in 2024

Which region highest CAGR the induced pluripotent stem cells market in 2024?

Asia Pacific region dominated the induced pluripotent stem cells market in 2024

Which segment accounts for highest revenue in Derived Cell Type segment of the induced pluripotent stem cells market in 2024?

The fibroblasts segment accounts for highest revenue in Derived Cell Type segment in 2024

Which are some of the major players operating in the market?

STEMCELL Technologies Inc.; Cellular Engineering Technologies Inc.; REPROCELL Inc.; Takara Bio, Inc.; Axol Bioscience Ltd.; Fate Therapeutics, Inc.; FUJIFILM Cellular Dynamics, Inc.; Cynata Therapeutics Limited; Evotec SE; Astellas Pharma Inc. some of the major market players operating in the market


  • STEMCELL Technologies Inc

  • Cellular Engineering Technologies Inc

  • REPROCELL Inc

  • Takara Bio, Inc

  • Axol Bioscience Ltd

  • Fate Therapeutics, Inc

  • FUJIFILM Cellular Dynamics, Inc

  • Cynata Therapeutics Limited

  • Evotec SE

  • Astellas Pharma Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.